Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic and Epigenetic Determinants of Chemotherapy Resistance and Adverse Outcome in Elderly Patients With AML

NCT01421875 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.

NCT NCT01421875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01421875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic and Epigenetic Determinants of Chemotherapy Resistance and Adverse Outcome in Elderly Patients With AML
Lead sponsor
Eastern Cooperative Oncology Group
Phase
Observational
Overall status
Completed
Start date
August 17, 2011
Completion date
October 17, 2011
Enrollment
257 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia